180 related articles for article (PubMed ID: 37474227)
1. Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study.
Auzenbergs M; Fu H; Abbas K; Procter SR; Cutts FT; Jit M
Lancet Glob Health; 2023 Aug; 11(8):e1194-e1204. PubMed ID: 37474227
[TBL] [Abstract][Full Text] [Related]
2. Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries.
Fu H; Abbas K; Klepac P; van Zandvoort K; Tanvir H; Portnoy A; Jit M
BMC Med; 2021 Nov; 19(1):281. PubMed ID: 34784922
[TBL] [Abstract][Full Text] [Related]
3. Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.
Doshi RH; Eckhoff P; Cheng A; Hoff NA; Mukadi P; Shidi C; Gerber S; Wemakoy EO; Muyembe-Tafum JJ; Kominski GF; Rimoin AW
Vaccine; 2017 Oct; 35(45):6187-6194. PubMed ID: 28966000
[TBL] [Abstract][Full Text] [Related]
4. Progress Toward Measles Elimination - South-East Asia Region, 2003-2020.
Khanal S; Kassem AM; Bahl S; Jayantha L; Sangal L; Sharfuzzaman M; Bose AS; Antoni S; Datta D; Alexander JP
MMWR Morb Mortal Wkly Rep; 2022 Aug; 71(33):1042-1046. PubMed ID: 35980874
[TBL] [Abstract][Full Text] [Related]
5. Measles control in Sub-Saharan Africa: South Africa as a case study.
Verguet S; Jassat W; Hedberg C; Tollman S; Jamison DT; Hofman KJ
Vaccine; 2012 Feb; 30(9):1594-600. PubMed ID: 22230581
[TBL] [Abstract][Full Text] [Related]
6. Progress Toward Measles Elimination - Pakistan, 2000-2018.
Mere MO; Goodson JL; Chandio AK; Rana MS; Hasan Q; Teleb N; Alexander JP
MMWR Morb Mortal Wkly Rep; 2019 Jun; 68(22):505-510. PubMed ID: 31170125
[TBL] [Abstract][Full Text] [Related]
7. International measles incidence and immunization coverage.
Hall R; Jolley D
J Infect Dis; 2011 Jul; 204 Suppl 1():S158-63. PubMed ID: 21666157
[TBL] [Abstract][Full Text] [Related]
8. Progress Toward Measles Elimination - European Region, 2009-2018.
Zimmerman LA; Muscat M; Singh S; Ben Mamou M; Jankovic D; Datta S; Alexander JP; Goodson JL; O'Connor P
MMWR Morb Mortal Wkly Rep; 2019 May; 68(17):396-401. PubMed ID: 31048675
[TBL] [Abstract][Full Text] [Related]
9. Progress Toward Measles Elimination - African Region, 2013-2016.
Masresha BG; Dixon MG; Kriss JL; Katsande R; Shibeshi ME; Luce R; Fall A; Dosseh ARGA; Byabamazima CR; Dabbagh AJ; Goodson JL; Mihigo R
MMWR Morb Mortal Wkly Rep; 2017 May; 66(17):436-443. PubMed ID: 28472026
[TBL] [Abstract][Full Text] [Related]
10. Evaluating effective measles vaccine coverage in the Malaysian population accounting for between-dose correlation and vaccine efficacy.
Kumar SS; Hartner AM; Chandran A; Gaythorpe KAM; Li X
BMC Public Health; 2023 Nov; 23(1):2351. PubMed ID: 38017415
[TBL] [Abstract][Full Text] [Related]
11. Immunization delivery in the second year of life in Ghana: the need for a multi-faceted approach.
Nyaku M; Wardle M; Eng JV; Ametewee L; Bonsu G; Larbi Opare JK; Conklin L
Pan Afr Med J; 2017; 27(Suppl 3):4. PubMed ID: 29296139
[TBL] [Abstract][Full Text] [Related]
12. Progress Toward Measles Elimination - Eastern Mediterranean Region, 2013-2019.
Goodson JL; Teleb N; Ashmony H; Musa N; Ghoniem A; Hassan Q; Waciqi AS; Mere MO; Farid M; Mukhtar HEA; Iqbal J; Alexander JP
MMWR Morb Mortal Wkly Rep; 2020 Apr; 69(15):439-445. PubMed ID: 32298253
[TBL] [Abstract][Full Text] [Related]
13. Progress in global measles control, 2000-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Feb; 61(4):73-8. PubMed ID: 22298303
[TBL] [Abstract][Full Text] [Related]
14. Multi-level determinants of failure to receive timely and complete measles vaccinations in Southwest China: a mixed methods study.
Tang XY; Cheng M; Geater A; Deng QY; Zhong G; Lin YD; Chen N; Lan T; Jiang LY; Zhu MT; Li Q
Infect Dis Poverty; 2021 Jul; 10(1):102. PubMed ID: 34294157
[TBL] [Abstract][Full Text] [Related]
15. Progress Toward Measles Elimination - Bangladesh, 2000-2016.
Khanal S; Bohara R; Chacko S; Sharifuzzaman M; Shamsuzzaman M; Goodson JL; Dabbagh A; Kretsinger K; Dhongde D; Liyanage J; Bahl S; Thapa A
MMWR Morb Mortal Wkly Rep; 2017 Jul; 66(28):753-757. PubMed ID: 28727678
[TBL] [Abstract][Full Text] [Related]
16. Impact of measles supplementary immunization activities on reaching children missed by routine programs.
Portnoy A; Jit M; Helleringer S; Verguet S
Vaccine; 2018 Jan; 36(1):170-178. PubMed ID: 29174680
[TBL] [Abstract][Full Text] [Related]
17. Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study.
Causey K; Fullman N; Sorensen RJD; Galles NC; Zheng P; Aravkin A; Danovaro-Holliday MC; Martinez-Piedra R; Sodha SV; Velandia-González MP; Gacic-Dobo M; Castro E; He J; Schipp M; Deen A; Hay SI; Lim SS; Mosser JF
Lancet; 2021 Aug; 398(10299):522-534. PubMed ID: 34273292
[TBL] [Abstract][Full Text] [Related]
18. Challenges Addressing Inequalities in Measles Vaccine Coverage in Zambia through a Measles-Rubella Supplementary Immunization Activity during the COVID-19 Pandemic.
Yang Y; Kostandova N; Mwansa FD; Nakazwe C; Namukoko H; Sakala C; Bobo P; Masumbu PK; Nachinga B; Ngula D; Carcelen AC; Prosperi C; Winter AK; Moss WJ; Mutembo S
Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992192
[TBL] [Abstract][Full Text] [Related]
19. Progress Toward Measles Elimination - Western Pacific Region, 2013-2017.
Hagan JE; Kriss JL; Takashima Y; Mariano KML; Pastore R; Grabovac V; Dabbagh AJ; Goodson JL
MMWR Morb Mortal Wkly Rep; 2018 May; 67(17):491-495. PubMed ID: 29723171
[TBL] [Abstract][Full Text] [Related]
20. Progress Toward Measles Elimination - Nepal, 2007-2014.
Khanal S; Sedai TR; Choudary GR; Giri JN; Bohara R; Pant R; Gautam M; Sharapov UM; Goodson JL; Alexander J; Dabbagh A; Strebel P; Perry RT; Bah S; Abeysinghe N; Thapa A
MMWR Morb Mortal Wkly Rep; 2016 Mar; 65(8):206-10. PubMed ID: 26937619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
